Biotech Values

[genisi]

I said I think "that the trial has better than 50% to be successful, but not so much because of the 'depleting the stroma' theory. My rationale is the phase 1/2 data on ORR, median OS and CA19-9 decreased levels, which were correlated with outcomes.